Other frequently prescribed medications, including statins (HMG-CoA reductase inhibitors), metformin, nonsteroidal anti-inflammatory medications (NSAIDs), and cyclooxygenase-2 (COX-2) inhibitors, have also been associated with a potentially reduced risk of gastric cancer development [11–13]. The gene discussed is PTGS2; the disease is gastric cancer.